等待开盘 07-14 09:30:00 美东时间
-7.560
-3.70%
今日重点评级关注:Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元;康托·菲茨杰拉德:维持BioCryst制药"超配"评级,目标价从27美元升至29美元
07-01 10:40
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wedbush raised the price target for Replimune Group Inc (NASDAQ:REPL) from $6 to $9. Wedbush analyst Robert Dr...
06-30 21:04
达登餐饮(DRI)将于7月10日进入除息日,位列7月值得买入的10只最佳股息股行列。6月26日两家机构先后调整其评级及目标价。 派珀·桑德勒将其目标价从20...
06-30 05:22
今日重点评级关注:杰富瑞:上调Tango Therapeutics评级至"买入",目标价从27美元升至60美元;Susquehanna:维持安森美半导体"积极"评级,目标价从120美元升至140美元
06-29 15:49
Darden Restaurants, Inc. (NYSE:DRI) reported mixed financial results for the fourth quarter on Thursday. The company reported quarterly adjusted earnings of $3.66 per share, which beat the analyst consensus estimate of $3.63 per share. The company posted quarterly sales of $3.719 billion, missing th...
06-26 21:25
BTIG维持对达登餐饮(DRI)的“买入”评级,将其目标价从225美元上调至235美元。本次调整紧随达登餐饮最新季度财报发布,该财报业绩喜忧参半:盈利超市场预期...
06-26 18:51
达登餐饮(DRI)披露2026财年第四季度及全年财报,核心营收、盈利数据超出市场预期,2026财年总营收首次突破130亿美元,同时将季度股息上调8%至每股1....
06-26 05:11
达登餐饮(NYSE:DRI)2026财年第四季度业绩、2027财年指引均不及市场预期,受消息影响股价下跌1.3%,当前交易价较52周高点低约5%,综合基本面与估...
06-26 00:53
达登餐饮周四发布2026财年第四季度财报,业绩表现分化,旗下部分品牌同店销售额不及预期,2027财年指引低于市场预期,公布后其盘前股价下跌超3%。 核心财报数据...
06-25 21:09